98 related articles for article (PubMed ID: 10095460)
1. [p53 overexpression as independent prognostic marker in soft tissue sarcomas is antibody dependent].
Würl P; Taubert H; Meye A; Berger D; Holzhausen HJ; Schmidt H; Hinze R; Rath FW; Schönfelder M
Verh Dtsch Ges Pathol; 1998; 82():358-61. PubMed ID: 10095460
[TBL] [Abstract][Full Text] [Related]
2. The p53 gene in soft tissue sarcomas: prognostic value of DNA sequencing versus immunohistochemistry.
Taubert H; Würl P; Bache M; Meye A; Berger D; Holzhausen HJ; Hinze R; Schmidt H; Rath FW
Anticancer Res; 1998; 18(1A):183-7. PubMed ID: 9568075
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas: a multivariate analysis of five antibodies.
Würl P; Taubert H; Meye A; Berger D; Lautenschläger C; Holzhausen HJ; Schmidt H; Kalthoff H; Rath FW; Dralle H
J Cancer Res Clin Oncol; 1997; 123(9):502-8. PubMed ID: 9341900
[TBL] [Abstract][Full Text] [Related]
4. [Frequency, distribution and prognostic relevance of p53 mutations in soft tissue sarcomas].
Taubert H; Würl P; Meye A; Bache M; Kroll J; Lautenschläger C; Thamm B; Holzhausen HJ; Hinze R; Schmidt H; Berger D; Rath FW
Verh Dtsch Ges Pathol; 1998; 82():340-4. PubMed ID: 10095457
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
Zhang Hong
Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
[TBL] [Abstract][Full Text] [Related]
6. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.
Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK
J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of p53 protein in uterine sarcomas.
Nordal RR; Kristensen GB; Stenwig AE; Tropé CG; Nesland JM
Gynecol Oncol; 1998 Jul; 70(1):45-8. PubMed ID: 9698472
[TBL] [Abstract][Full Text] [Related]
8. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
[TBL] [Abstract][Full Text] [Related]
10. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
11. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
[TBL] [Abstract][Full Text] [Related]
13. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
Yu H; Levesque MA; Clark GM; Diamandis EP
Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
[TBL] [Abstract][Full Text] [Related]
14. High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities.
Würl P; Meye A; Schmidt H; Lautenschläger C; Kalthoff H; Rath FW; Taubert H
Oncogene; 1998 Mar; 16(9):1183-5. PubMed ID: 9528860
[TBL] [Abstract][Full Text] [Related]
15. P53 is an independent prognostic factor for survival in thyroid cancer.
Bachmann K; Pawliska D; Kaifi J; Schurr P; Zörb J; Mann O; Kahl HJ; Izbicki JR; Strate T
Anticancer Res; 2007; 27(6B):3993-7. PubMed ID: 18225561
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of p53 protein overexpression versus gene sequencing in urinary bladder carcinomas.
Bernardini S; Adessi GL; Billerey C; Chezy E; Carbillet JP; Bittard H
J Urol; 1999 Oct; 162(4):1496-501. PubMed ID: 10492244
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
Turner BC; Gumbs AA; Carbone CJ; Carter D; Glazer PM; Haffty BG
Cancer; 2000 Mar; 88(5):1091-8. PubMed ID: 10699900
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Wilms tumor gene (WT1) mRNA expression in soft tissue sarcoma.
Sotobori T; Ueda T; Oji Y; Naka N; Araki N; Myoui A; Sugiyama H; Yoshikawa H
Cancer; 2006 May; 106(10):2233-40. PubMed ID: 16607650
[TBL] [Abstract][Full Text] [Related]
19. Association of positive serum anti-p53 antibodies with poor prognosis in bladder cancer patients.
Gumus E; Erdamar S; Demirel G; Horasanli K; Kendirci M; Miroglu C
Int J Urol; 2004 Dec; 11(12):1070-7. PubMed ID: 15663677
[TBL] [Abstract][Full Text] [Related]
20. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
